SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-035837
Filing Date
2021-05-25
Accepted
2021-05-25 21:06:08
Documents
1
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4902
  Complete submission text file 0001209191-21-035837.txt   6378
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O ATYR PHARMA, INC. 3545 JOHN HOPKINS COURT, SUITE 250 SAN DIEGO CA 92121
Business Address
DENYES NANCY (Reporting) CIK: 0001640869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 21962509